Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Daboia siamensis factor V activator is a potent procoagulant serine protease found in the venom of the Eastern Russell's Viper. Unlike many other snake venom procoagulants that are metalloproteinases, this specific toxin is a highly specific serine protease that activates host Factor V by cleaving the heavy chain-light chain junction, mimicking the action of thrombin but without the regulatory feedback mechanisms. This activation leads to the rapid formation of the prothrombinase complex, resulting in massive thrombin generation and subsequent consumptive coagulopathy in snakebite victims. In a clinical context, this molecule is the primary target for therapeutic antivenoms, which aim to neutralize its enzymatic activity to prevent life-threatening systemic bleeding and disseminated intravascular coagulation. Beyond its role in pathology, the toxin is utilized in diagnostic laboratory medicine to assay Factor V levels in human plasma.
Antivenoms work by polyclonal antibody-mediated neutralization of the toxin's enzymatic activity and facilitating its clearance from the systemic circulation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Daboia siamensis factor V activator (DsVVA).